Dowden Nathan J

Entrada Therapeutics, Inc. ยท President & COO

Dowden Nathan J is listed in public filings as officer: President & COO. This Dowden Nathan J insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Entrada Therapeutics, Inc. (TRDA). Investors use Dowden Nathan J's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Entrada Therapeutics, Inc.TRDA$3.0M198.6k sharesSellMay 4, 2026$230.0K15k shares$15.33--
Entrada Therapeutics, Inc.TRDA$87k49.8k sharesGrant / ExerciseMay 4, 2026$26.1K15k shares$1.74--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Entrada Therapeutics, Inc.TRDA$2.6M198.6k sharesSellMar 10, 2026$155.2K11.9k shares$13.05--
Entrada Therapeutics, Inc.TRDA$2.7M210.5k sharesSellMar 9, 2026$40.6K3.1k shares$13.02--
Entrada Therapeutics, Inc.TRDA$2.5M213.6k sharesGrant / ExerciseMar 3, 2026$165.0K14k shares$11.76--
Entrada Therapeutics, Inc.TRDA$2.7M227.6k sharesGrant / ExerciseMar 2, 2026$84.2K7.2k shares$11.66--
Entrada Therapeutics, Inc.TRDA$993k83.2k sharesGrant / ExerciseMar 1, 2026$992.6K83.2k shares$11.93--
Entrada Therapeutics, Inc.TRDA--234.9k sharesGrant / ExerciseMar 1, 2026Disclosure amount unavailable55.8k shares----
Entrada Therapeutics, Inc.TRDA$972k179.1k sharesGrant / ExerciseSep 2, 2025$9.5K1.7k shares$5.43--
Entrada Therapeutics, Inc.TRDA$2.1M180.8k sharesGrant / ExerciseMar 3, 2025$60.1K5.1k shares$11.68--
Entrada Therapeutics, Inc.TRDA$1.1M90.8k sharesGrant / ExerciseMar 1, 2025$1.1M90.8k shares$11.94--
Entrada Therapeutics, Inc.TRDA--185.9k sharesGrant / ExerciseMar 1, 2025Disclosure amount unavailable60.8k shares----
Entrada Therapeutics, Inc.TRDA$2.0M125.1k sharesSellSep 26, 2024$13.6K847 shares$16.00--
Entrada Therapeutics, Inc.TRDA$1.9M126k sharesSellSep 9, 2024$28.7K1.9k shares$15.07--
Entrada Therapeutics, Inc.TRDA$1.9M127.9k sharesSellSep 6, 2024$6.1K399 shares$15.19--
Entrada Therapeutics, Inc.TRDA$1.9M128.3k sharesGrant / ExerciseSep 5, 2024$2.6K171 shares$15.13--
Entrada Therapeutics, Inc.TRDA$2.0M128.5k sharesGrant / ExerciseSep 4, 2024$15.2K983 shares$15.42--
Entrada Therapeutics, Inc.TRDA$2.2M129.5k sharesGrant / ExerciseSep 3, 2024$2.6K156 shares$16.93--
Entrada Therapeutics, Inc.TRDA$2.3M129.5k sharesGrant / ExerciseSep 3, 2024$26615 shares$17.70--
Entrada Therapeutics, Inc.TRDA$2.0M129.6k sharesGrant / ExerciseSep 3, 2024$7.6K483 shares$15.76--
Entrada Therapeutics, Inc.TRDA$2.1M130.6k sharesSellAug 16, 2024$432.4K26.6k shares$16.26--
Entrada Therapeutics, Inc.TRDA$113k64.8k sharesGrant / ExerciseAug 16, 2024$34.8K20k shares$1.74--
Entrada Therapeutics, Inc.TRDA$2.2M130.1k sharesSellAug 16, 2024$8.4K502 shares$16.70--